Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenase

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 34, 2012, Pages 13823-13828

  Lijek, Rebeccah S ^a   Luque, Santiago L ^a   Liu, Qian ^b   Parker, Dane ^c   Bae, Taeok ^b   Weiser, Jeffrey N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE NORTHWEST   (United States)

^c Columbia University ^*  (United States)

Author keywords

Methicillin resistant S. Aureus; Pneumococcus; Vaccine

Indexed keywords

BACTERIAL PROTEIN; OXIDOREDUCTASE; PYRROLINE 5 CARBOXYLATE DEHYDROGENASE; SP1119 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIGENS; CARRIER STATE; GENE DELETION; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MODELS, GENETIC; MUTATION; NASAL MUCOSA; OXIDOREDUCTASES; PNEUMOCOCCAL VACCINES; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84865306276     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1208075109     Document Type: Article

References (38)

1. Klevens RM, et al.; National Nosocomial Infections Surveillance System (2006) Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 42:389-391.
2. Moran GJ, Amii RN, Abrahamian FM, Talan DA (2005) Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 11:928-930.
3. Wertheim HF, et al. (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5:751-762.
4. von Eiff C, Becker K, Machka K, Stammer H, Peters G; Study Group (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 344:11-16.
5. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505-520.
6. Bogaert D, et al. (2004) Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363:1871-1872.
7. Kwambana BA, Barer MR, Bottomley C, Adegbola RA, Antonio M (2011) Early acquisition and high nasopharyngeal co-colonisation by Streptococcus pneumoniae and three respiratory pathogens amongst Gambian new-borns and infants. BMC Infect Dis 11:175-183.
8. Madhi SA, et al. (2007) Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae - and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization - in HIV-Infected and HIV-uninfected children. J Infect Dis 196:1662-1666.
9. McNally LM, et al. (2006) Lack of association between the nasopharyngeal carriage of Streptococcus pneumoniae and Staphylococcus aureus in HIV-1-infected South African children. J Infect Dis 194:385-390.
10. Pettigrew MM, Gent JF, Revai K, Patel JA, Chonmaitree T (2008) Microbial interactions during upper respiratory tract infections. Emerg Infect Dis 14:1584-1591.
11. Regev-Yochay G, et al. (2004) Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children. JAMA 292:716-720.
12. Regev-Yochay G, et al.; Maccabi Implementing Judicious Antibiotic Prescription Study Group (2009) Parental Staphylococcus aureus carriage is associated with staphylococcal carriage in young children. Pediatr Infect Dis J 28:960-965.
13. van Gils EJ, et al. (2011) Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PLoS ONE 6: e20229.
14. Watson K, et al.; Kalgoorlie Otitis Media Research Project Team (2006) Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia. Pediatr Infect Dis J 25:782-790.
15. Veenhoven R, et al. (2003) Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: A randomised study. Lancet 361:2189-2195.
16. Park B, Nizet V, Liu GY (2008) Role of Staphylococcus aureus catalase in niche competition against Streptococcus pneumoniae. J Bacteriol 190:2275-2278.
17. Regev-Yochay G, Trzcinski K, Thompson CM, Malley R, Lipsitch M (2006) Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J Bacteriol 188:4996-5001.
18. Selva L, et al. (2009) Killing niche competitors by remote-control bacteriophage induction. Proc Natl Acad Sci USA 106:1234-1238.
19. Margolis E (2009) Hydrogen peroxide-mediated interference competition by Streptococcus pneumoniae has no significant effect on Staphylococcus aureus nasal colonization of neonatal rats. J Bacteriol 191:571-575.
20. Melles DC, et al. (2007) Nasopharyngeal co-colonization with Staphylococcus aureus and Streptococcus pneumoniae in children is bacterial genotype independent. Microbiology 153:686-692.
21. Regev-Yochay G, et al. (2008) In vitro bactericidal activity of Streptococcus pneumoniae and bactericidal susceptibility of Staphylococcus aureus strains isolated from cocolonized versus noncocolonized children. J Clin Microbiol 46:747-749.
22. Crook DW, Brueggemann AB, Sleeman KL, Peto TEA (2004) The Pneumococcus, ed Tuomanen E (ASM, Washington, DC), pp 136-147.
23. Bogaert D, Nouwen J, Hermans PW, Belkum A (2006) Lack of Interference between Streptococcus pneumoniae and Staphylococcus aureus in HIV-infected individuals? J Infect Dis 194:1617-1618, author reply 1618-1619.
24. Lebon A, et al. (2011) The inverse correlation between Staphylococcus aureus and Streptococcus pneumoniae colonization in infants is not explained by differences in serum antibody levels in the Generation R Study. Clin Vaccine Immunol 18:180-183.
25. Light IJ, Walton RL, Sutherland JM, Shinefield HR, Brackvogel V (1967) Use of bacterial interference to control a staphylococcal nursery outbreak. Deliberate colonization of all infants with the 502A strain of Staphylococcus aureus. Am J Dis Child 113:291-300.
26. Iwase T, et al. (2010) Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465:346-349.
27. McCool TL, Cate TR, Moy G, Weiser JN (2002) The immune response to pneumococcal proteins during experimental human carriage. J Exp Med 195:359-365.
28. Roche AM, King SJ, Weiser JN (2007) Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect Immun 75:2469-2475.
29. Schneerson R, Robbins JB (1975) Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5. N Engl J Med 292:1093-1096.
30. Holtfreter S, et al. (2009) Human immune proteome in experimental colonization with Staphylococcus aureus. Clin Vaccine Immunol 16:1607-1614.
31. Clarke SR, et al. (2006) Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J Infect Dis 193:1098-1108.
32. Sophos NA, Vasiliou V (2003) Aldehyde dehydrogenase gene superfamily: The 2002 update. Chem Biol Interact 143-144:5-22.
33. Chhatwal GS (2002) Anchorless adhesins and invasins of Gram-positive bacteria: A new class of virulence factors. Trends Microbiol 10:205-208.
34. Barbour ML, Mayon-White RT, Coles C, Crook DW, Moxon ER (1995) The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 171:93-98.
35. Dagan R, et al. (2005) Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J Infect Dis 192:367-376.
36. Schaffer AC, et al. (2006) Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect Immun 74:2145-2153.
37. Fitzwater SP, Chandran A, Santosham M, Johnson HL (2012) The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 31:501-508.
38. Malley R, et al. (2001) Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun 69:4870-4873.